University of Limerick pharma centre to get share of €300m

Nick Rabbitts

Reporter:

Nick Rabbitts

A PHARMACEUTICAL research centre at the University of Limerick is one of seven nationwide to benefit from €300m in funding.

A PHARMACEUTICAL research centre at the University of Limerick is one of seven nationwide to benefit from €300m in funding.

Minister for Research and Innovation Sean Sherlock has confirmed that the Synthesis and Solid State Pharmaceutical Centre (SSPC) is in line to receive a share of the funding, designed to help scientists develop cutting-edge technologies.

Some €200m of this fund is coming from government, while the remainder of €100m is being given in cash and contributions from 150 companies. The centre in Limerick will pursue drug development and synthesis.

Limerick City TD Kieran O’Donnell welcomed the funding, the largest of its type in the state.

“The programme is designed to support top-class research that will lead to job creation and help attract investment in Ireland into the future. The seven centres being funded were selected from 35 proposals following a rigorous process. The SSPC at UL will develop new mechanisms and better control processes to produce new and improved drug formulations and safe medicines. This centre is of major importance to Ireland’s pharmaceutical sector, which directly employs 25,000 people in Ireland and accounted for 56% of all Irish exports last year,” he explained.

He feels the funding boost from the SSPC is a recognition of the quality of work taking place in UL.

He acknowledged the work of Prof Kieran Hobnett in leading the SSPC, and to Dr. Mary Shire, UL’s Vice-President of research in securing this funding, which will see research jobs in UL.

“I look forward to working further with UL in order to secure further state support in programmes that will lead to job creation,” he concluded.